Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort
NCT ID: NCT02085850
Last Updated: 2014-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1375 participants
OBSERVATIONAL
2014-03-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim 2: To characterise the progression of glaucoma and the outcomes of subjects diagnosed with glaucoma in the Tema Eye Survey.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Ghana Primary Tube Versus Trabeculectomy Study
NCT02088528
mRNA Expression in Lymphocytes of Glaucoma Patients
NCT00327509
Saccadic Eye Movements Are Impaired In Glaucoma
NCT01254058
Dresden Glaucoma and Treatment Study (DGTS)
NCT02959242
Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma
NCT01855802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects identified in the Tema Eye Survey
Subjects identified in the Tema Eye Survey
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tema Christian Eye Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alex Spratt
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Spratt, MBBCh FRCOphth
Role: PRINCIPAL_INVESTIGATOR
Tema Christian Eye Center
Donald L Budenz, MD MPH
Role: STUDY_CHAIR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tema Christian Eye Center
Tema, , Ghana
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TCEC 066/13-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.